Authors:
GLASS B
ZEIS M
UHAREK L
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MUELLERRUCHHOLTZ W
Citation: B. Glass et al., HUMAN ALLOGENEIC NK-CELLS ACTIVATED BY IL-2 AND IL-12 EFFICIENTLY LYSE FRESH ACUTE-LEUKEMIA BLASTS, European journal of cancer, 31A, 1995, pp. 36-36
Authors:
ZEIS M
UHAREK L
GLASS B
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MULLERRUCHHOLTZ W
Citation: M. Zeis et al., ALLOGENEIC NK CELLS AS POTENT ANTILEUKEMIC EFFECTOR-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MICE, Transplantation, 59(12), 1995, pp. 1734-1736
Authors:
ZEIS M
UHAREK L
GLASS B
GASKA T
GASSMANN W
MUELLERRUCHHOLTZ W
Citation: M. Zeis et al., INDUCTION OF GRAFT-VERSUS-LEUKEMIA (GVL) ACTIVITY IN MURINE LEUKEMIA MODELS AFTER IL-2 PRETREATMENT OF SYNGENEIC AND ALLOGENEIC BONE-MARROWGRAFTS, Bone marrow transplantation, 14(5), 1994, pp. 711-715
Authors:
UHAREK L
GLASS B
GASKA T
GASSMANN W
LOEFFLER H
MUELLERRUCHHOLTZ W
Citation: L. Uharek et al., INFLUENCE OF DONOR LYMPHOCYTES ON THE INCIDENCE OF PRIMARY GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A MURINE MODEL, British Journal of Haematology, 88(1), 1994, pp. 79-87
Authors:
ZEIS M
UHAREK L
GLASS B
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MUELLERRUCHHOLTZ W
Citation: M. Zeis et al., IMMUNOTHERAPEUTIC TRANSFER OF ALLOGENEIC NK CELLS CAN ERADICATE LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MICE, Blood, 84(10), 1994, pp. 10000098-10000098
Authors:
UHAREK L
ZEIS M
GLASS B
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MUELLERRUCHHOLTZ W
Citation: L. Uharek et al., ALLOGENEIC HUMAN NK CELLS ACTIVATED BY IL-2 AND IL-12 EFFECTIVELY LYSE ACUTE LEUKEMIAS, Blood, 84(10), 1994, pp. 10000501-10000501
Authors:
GLASS B
UHAREK L
ZEIS M
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MUELLERRUCHHOLTZ W
Citation: B. Glass et al., CELLULAR IMMUNOTHERAPY OF ACUTE LEUKEMIAS AFTER HIGH-DOSE CHEMOTHERAPY IN A MURINE MODEL, Blood, 84(10), 1994, pp. 10000728-10000728
Authors:
GLASS B
UHAREK L
GASKA T
GASSMANN W
LOFFLER H
MULLERRUCHHOLTZ W
Citation: B. Glass et al., THE INFLUENCE OF GRAFT-VERSUS-HOST REACTIVITY, LYMPHOCYTE DEPLETION, AND CELL DOSE ON ALLOGENEIC BONE-MARROW ENGRAFTMENT, Bone marrow transplantation, 12, 1993, pp. 190000041-190000047
Authors:
UHAREK L
GLASS B
GASKA T
ZEISS M
GASSMANN W
LOFFLER H
MULLERRUCHHOLTZ W
Citation: L. Uharek et al., NATURAL-KILLER-CELLS AS EFFECTOR-CELLS OF GRAFT-VERSUS-LEUKEMIA ACTIVITY IN A MURINE TRANSPLANTATION MODEL, Bone marrow transplantation, 12, 1993, pp. 190000057-190000060
Authors:
GLASS B
UHAREK L
GASKA T
ZEIS M
GASSMANN W
OEFFLER H
MUELLERRUCHHOLTZ W
Citation: B. Glass et al., CELLULAR IMMUNOTHERAPY USING ALLOGENEIC LYMPHOCYTES FOLLOWING BONE-MARROW TRANSPLANTATION IN A MURINE LEUKEMIA MODEL, Blood, 82(10), 1993, pp. 10000306-10000306
Authors:
UHAREK L
GLASS B
ULLERICH H
GASKA T
GASSMANN W
LOEFFLER H
MUELLERRUCHHOLTZ W
Citation: L. Uharek et al., DIFFERENCES IN NATURAL-KILLER (NK) CELL ALLOREACTIVITY AGAINST ACUTE-LEUKEMIA BLASTS, Blood, 82(10), 1993, pp. 10000521-10000521